If I had to guess the sort of healthcare company that would get a premium
acquisition offer,
Lincare (Nasdaq:
LNCR)
would be low on my list, as relatively few buyers would want to pay a
premium to get into a business that is beset by constant reimbursement
pressures. But, as the old saying goes, you only need one buyer to make a
deal and Lincare found that one.
In a deal that reverses a spin-out from nearly 25 years ago, German industrial gases company
Linde
will be acquiring Lincare for $4.6 billion in total considerations.
That works out to $41.50 per share for Lincare's shareholders; a 22%
premium to Friday's
closing price (which had been moving up on takeover rumors) and a whopping 67% premium to the stock's three-month average price.
Continue here:
http://stocks.investopedia.com/stock-analysis/2012/Lincare-Shows-That-You-Can-Go-Home-Again-LNCR-APD-PX-AMED0704.aspx
No comments:
Post a Comment